Dynavax Teams Up With Mt Sinai On Universal Flu Vaccine
The Media's Jihad Against Sweden's No-Lockdown Policy Ignores Key Facts
Coronavirus pharma news roundup – 17/07/20
Orexo launches digital therapies for depression, alcohol misuse early in US
Inferring Covid-19 Fatalities
U.S. shatters coronavirus record with over 77,000 cases in a day
As The Economy Reopened, This Is Where Job Applications Surged
State-Linked Chinese Firm Uses Own Workers As Guinea Pigs In Unregulated Vaccine "Pre-Test"
Tourists to P.E.I. during COVID-19 find a familiar mix of hospitality and hostility
Charts of the Week: Tracking deaths of despair; the pandemic’s economic damage; uneven PPP distribution in metros
Some decontamination processes damage N95 face masks
Moving high-stakes exams online: Five points to consider
Bonds Bid, Stocks Skid, As Banks & Big-Tech Breakdown
Will telehealth services become the norm following COVID-19 pandemic?
Here We Are: 5 Stories That Got Us To Now
3 "Strong Buy" Penny Stocks That Could Rally to $10 (Or More)
Joblessness remains at historic levels: The extra $600 in UI benefits expires next week, Congress must extend it
2019 brought private investment in infrastructure to more countries: Is there a message for policymakers amid COVID-19?
Unemployed Americans Spent More With $600 Weekly Boost Than Before Pandemic; That's About To Go Away
COVID-19: Unearthing the ties that bind
Scientists Discover That One Big Assumption That Everyone Has Been Making About COVID-19 May Be Dead Wrong
Soon, You Will Need To Wear A Mask To Enter Virtually Every Major Retail Store In America
Avoiding food contamination with a durable coating for hard surfaces
Russia trying to steal COVID-19 vaccine data, say UK, U.S. and Canada
Euro Little Changed As ECB Leaves Interest Rates, QE Program Unchanged
Novartis To Sell Covid-19 Drugs At Zero-Profit To Low-Income Countries
Global research community asks for the right research in the right places for COVID-19
Antibody legend Tillman Gerngross is elbowing his way into the Covid-19 R&D crusade: 'I don’t see this ending anytime soon'
Over 50 Million Americans Have Now Filed For First-Time Jobless Benefits Since Lockdowns Began
Contact tracing's long, turbulent history holds lessons for COVID-19